Article information
Full text is only aviable in PDF
REFERENCES
[1]
PW Jones.
Interpreting thresholds for a clinically significant change in health status in asthma and COPD.
Eur Respir J., 19 (2002), pp. 398-404
[2]
TAR Seemungal, GC Donaldson, EA Paul, JC Bestall, DJ Jeffries, JA Wedzicha.
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med., 157 (1998), pp. 1418-1422
[3]
M Miravitlles, M Ferrer, A Pont, R Zalacain, JL Álvarez-Sala, F Masa, et al.
Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study.
Thorax, 59 (2004), pp. 387-395
[4]
S Spencer, PW Jones, GLOBE Study Group.
Time course of recovery of health status following an infective exacerbation of chronic bronchitis.
Thorax, 58 (2003), pp. 589-593
[5]
S Spencer, PM Calverley, PS Burge, PW Jones.
Impact of preventing exacerbations on deterioration of health status in COPD.
Eur Respir J., 23 (2004), pp. 698-702
[6]
P Almagro, E Calbo, A Ochoa de Echaguen, B Barreiro, S Quintana, JL Heredia, et al.
Mortality after hospitalization for COPD.
Chest, 121 (2002), pp. 1441-1448
[7]
A Domingo-Salvany, R Lamarca, M Ferrer, J García-Aymerich, J Alonso, M Félez, et al.
Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med., 166 (2002), pp. 680-685
[8]
R Harper, JE Brazier, JC Waterhouse, SJ Walters, NMB Jones, P Howard.
Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting.
Thorax, 52 (1997), pp. 879-887
[9]
R Desikan, HL Mason, MT Rupp, M Skehan.
Health-related quality of life and healthcare resource utilization by COPD patients: a comparison of three instruments.
Qual Life Res., 11 (2002), pp. 739-751
[10]
GH Guyatt, DR King, DH Feeny, D Stubbing, RS Goldstein.
Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation.
J Clin Epidemiol., 52 (1999), pp. 187-192
[11]
JP de Torres, V Pinto-Plata, E Ingenito, P Bagley, A Gray, R Berger, et al.
Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD.
Chest, 121 (2002), pp. 1092-1098
[12]
M Tsukino, K Nishimura, SP McKenna, A Ikeda, T Hajiro, M Zhang, et al.
Change in generic and disease-specific health-related quality of life during a one-year period in patients with newly detected chronic obstructive pulmonary disease.
Respiration, 69 (2002), pp. 513-520
[13]
H Doll, I Duprat-Lomon, E Ammerman, PP Sagnier.
Validity of the St. George's respiratory questionnaire at acute exacerbation of chronic bronchitis: comparison with the Nottingham health profile.
Qual Life Res., 12 (2003), pp. 117-132
[14]
JE Ware, JP Kemp, DA Buchner, AE Singer, KB Nolop, TF Goss.
The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults.
Qual Life Res., 7 (1998), pp. 235-244
[15]
MPMH Rutten-van Mölken, F Custers, EKA van Doorslaer, CCM Jansen, L Heurman, FPV Maesen, et al.
Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life.
Eur Respir J., 8 (1995), pp. 888-898
[16]
T van der Molen, DS Postma, AJM Schreurs, HEP Bosveld, MR Sears, B Meyboom de Jong.
Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma.
Qual Life Res., 6 (1997), pp. 353-361
[17]
T van der Molen, MR Sears, CS de Graaff, DS Postma, B Meyboomde Jong, the Canadian and the Dutch formoterol investigators.
Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires.
Eur Respir J., 12 (1998), pp. 30-34
[18]
EF Juniper, GR Norman, FM Cox, JN Roberts.
Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma.
Eur Respir J., 18 (2001), pp. 38-44
[19]
JR Curtis, DL Patrick.
The assessment of health status among patients with COPD.
Eur Respir J., 21 (2003), pp. 36s-45s
[20]
CP Engström, LO Persson, S Larsson, M Sullivan.
Health-related quality of life in COPD: why both disease specific and generic measures should be used.
Eur Respir J., 18 (2001), pp. 69-76
[21]
MA Martínez García, M Perpiñá Tordera, P Román Sánchez, JJ Soler Cataluña.
Consistencia interna y validez de la versión española del St. George's Respiratory Questionnaire para su uso en pacientes afectados de bronquiectasias clínicamente estables.
Arch Bronconeumol., 41 (2005), pp. 110-117
[22]
PW Jones, FH Quirk, CM Baveystock, P Littlejohns.
A self-complete measure of health status for chronic airflow limitation. The St George' Respiratory Questionnaire.
Am Rev Respir Dis., 145 (1992), pp. 1321-1327
[23]
M Ferrer, J Alonso, L Prieto, V Plaza, E Monsó, R Marrades, et al.
Validity and reliability of the St. George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example.
Eur Respir J., 9 (1996), pp. 1160-1166
[24]
C Sanjuás, J Alonso, L Prieto, M Ferrer, JM Broquetas, JM Antó.
Health related quality of life in asthma: a comparison between the St George's Respiratory Questionnaire and the Asthma Quality of Life Questionnaire.
Qual Life Res., 11 (2002), pp. 729-738
[25]
CB Wilson, PW Jones, CJ O'Leary, PJ Cole, R Wilson.
Validation of the St George's Respiratory Questionnaire in bronchiectasis.
Am J Respir Crit Care Med., 156 (1997), pp. 536-541
[26]
CB Wilson, PW Jones, CJ O'Leary, DM Hansell, PJ Cole, R Wilson.
Effect of sputum bacteriology on the quality of life of patients with bronchiectasis.
Eur Respir J., 10 (1997), pp. 1754-1760
[27]
C Hernández, J Abreu, A Jiménez, R Fernández, C Martín.
Función pulmonar y calidad de vida en relación con la colonización bronquial en adultos con bronquiectasias no debidas afibrosis quística.
Med Clin (Barc), 118 (2002), pp. 130-134
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
